Michael D. Miedema
Michael D. Miedema publishes mostly in Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, on topics such as Cardiac Imaging and Diagnostics, Lipoproteins and Cardiovascular Health and Cardiovascular Disease and Adiposity.
- World rank
- #210,111 of 7,710,434 ranked researchers
- Rank in United States
- #77,914 of 1,627,098
- Works
- 219
- Citations
- 18k
- Citations per work
- 82.4
What does Michael D. Miedema research?
Michael D. Miedema's work is mostly in Medicine (71%), Economics, Econometrics and Finance (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences15671.2%
- Medicine15671.2%
- Everything else5525.1%
- Social Sciences83.7%
- 1Cardiology and Cardiovascular Medicine33% of their works
- 2Radiology, Nuclear Medicine and Imaging16% of their works
- 3Surgery15% of their works
- 4Pulmonary and Respiratory Medicine4% of their works
- 5Economics and Econometrics4% of their works
- 6Endocrinology, Diabetes and Metabolism3% of their works
Research topics
- Cardiac Imaging and Diagnostics
- Lipoproteins and Cardiovascular Health
- Cardiovascular Disease and Adiposity
- Cardiovascular Health and Risk Factors
- Acute Myocardial Infarction Research
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Coronary Interventions and Diagnostics
Which keywords describe Michael D. Miedema's research?
The keywords of their largest research topics: Myocardial Infarction, Coronary Artery Disease, Cardiac Imaging, Myocardial Perfusion, Cardiovascular Disease, Cholesterol-lowering, Statins and Atherosclerosis.
- Myocardial Revascularization
- Quality of Life
- Depression
- ST-Segment Elevation
- Ideal Cardiovascular Health
- Perivascular Adipose Tissue
- Atherosclerosis
- Cholesterol-lowering
- Myocardial Perfusion
- Coronary Artery Disease
- Myocardial Infarction
- Cardiac Imaging
- Cardiovascular Disease
- Statins
- Epicardial Fat
- Cardiovascular Health
- Acute Coronary Syndromes
- Cardiac Rehabilitation
- Cost-effectiveness Analysis
- Coronary Stents
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Myocardial Infarction1353 topics
- Coronary Artery Disease1252 topics
- Cardiac Imaging881 topic
- Myocardial Perfusion881 topic
- Cardiovascular Disease662 topics
- Cholesterol-lowering601 topic
- Statins601 topic
- Atherosclerosis502 topics
- Epicardial Fat371 topic
- Perivascular Adipose Tissue371 topic
- Cardiovascular Health361 topic
- Ideal Cardiovascular Health361 topic
- Acute Coronary Syndromes291 topic
- ST-Segment Elevation291 topic
- Cardiac Rehabilitation181 topic
- Depression181 topic
- Cost-effectiveness Analysis141 topic
- Quality of Life141 topic
- Coronary Stents131 topic
- Myocardial Revascularization131 topic
Where does Michael D. Miedema work?
Michael D. Miedema's main affiliation in the publication record is Minneapolis Heart Institute Foundation, United States.
How many publications and citations does Michael D. Miedema have?
OpenAlex counts 219 works and 18,040 citations for Michael D. Miedema, an h-index of 42, ranking #210,111 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael D. Miedema. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.